J&J's Erleada Approved By FDA In New Prostate Cancer Indication

 
• By Jessica Merrill
  
Prostate-cancer
Erleada was approved by FDA for metastatic castration-sensitive prostate cancer
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anticancer

More from Therapeutic Category